Keyphrases
Glucose-dependent Insulinotropic Polypeptide
100%
Type I Diabetes
66%
Type 1 Diabetes Mellitus (T1DM)
66%
Inflammatory Cytokines
58%
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
58%
Human Islets
57%
Microtissue
50%
Polypeptide 1
50%
Transcriptomics
50%
B Cells
50%
Incretin
50%
In Vitro Model
50%
Alpha Cell
50%
Type 1 Diabetic
50%
Glucagon Secretion
41%
Caspase 3/7 Activity
33%
Chemokine Secretion
33%
Interferon-α (IFN-α)
33%
MHC Class II
33%
Mitochondrial Function
33%
Cytotoxicity
33%
Immunoblotting
33%
Dose Effect
25%
Tumor Necrosis Factor-α
25%
Meso Scale Discovery
25%
Interleukin-1β
25%
Liraglutide
25%
Sensitivity Profile
16%
Stress Markers
16%
Newly Established
16%
Cell Death
16%
Endoplasmic Reticulum Stress (ER stress)
16%
Apoptotic Effect
16%
Toxic Effects
16%
Global Gene Expression
16%
Human Leukocyte Antigen Genes
16%
Time Course Experiment
16%
Non-coding RNA (ncRNA)
16%
Extracellular Flux
16%
Differentially Expressed Genes
16%
TUNEL Assay
16%
Immunofluorescence
16%
Type 1 Diabetes Risk
16%
Quantitative PCR
16%
Electrochemiluminescence
16%
Chemokine Production
16%
Insulin Secretion
16%
RNA Sequencing (RNA-seq)
16%
Immune Response
16%
Signal Transduction
16%
Biochemistry, Genetics and Molecular Biology
Gastric Inhibitory Polypeptide
100%
Cytokine
75%
Receptor Agonists
66%
Proinflammatory Cytokine
58%
Gastric Inhibitory Polypeptide Receptor
58%
Incretin
50%
Transcriptomics
50%
Glucagon Release
41%
Liraglutide
25%
Glucose Blood Level
21%
Glucagon-Like Peptide 1 Receptor
16%
Cell Function
16%
Major Histocompatibility Complex
14%
Secretion (Process)
14%
Interferon
14%
interferon
14%
Chemokine
14%
Signal Transduction
14%
Western Blot
14%
Cytotoxicity
14%
Caspase 3
14%
Glucagon
10%
Tumor Necrosis Factor Alpha
8%
Exercise
8%
Glycemic Control
8%
Glucose Metabolism
7%
Bone Metabolism
7%
Tumor Necrosis Factor
7%
Gene Expression
7%
Interleukin-1
7%
Cell Death
7%
Human Leukocyte Antigen
7%
Endoplasmic Reticulum Stress
7%
Real-Time Polymerase Chain Reaction
7%
Extracellular Flux
7%
Non-Coding RNA
7%
Upregulation
7%
RNA Sequence
7%
Immunofluorescence
7%
Electrochemiluminescence
7%
Insulin Release
7%
Transcriptome
7%
TUNEL Assay
7%
Glucose Level
5%
Medicine and Dentistry
Gastric Inhibitory Polypeptide
100%
Receptor
57%
In Vitro
55%
Incretin
50%
Diabetes Mellitus
50%
Insulin Dependent Diabetes Mellitus
42%
Glucagon Release
35%
Cytokine
28%
Liraglutide
21%
Hypoglycemia
21%
Cell Function
14%
Glucagon
9%
Bone Metabolism
7%
Glucose Metabolism
7%
Insulin Treatment
7%
Interleukin 1beta
7%
Glycemic Control
7%
Blood Glucose
7%
Glucagon-Like Peptide-1 Agonist
7%
Organ Donor
7%
Tumor Necrosis Factor
7%
Complications of Diabetes Mellitus
7%
Clinical Finding
7%
Exercise
7%
Glucagon Like Peptide 1 Receptor
7%
Infusion
5%
